FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   DAVILA ELIZABETH H 2. Date of Event Requiring Statement (Month/Day/Year) 05/27/2005 3. Issuer Name and Ticker or Trading Symbol ADVANCED MEDICAL OPTICS INC [AVO] (Last) (First) (Middle) C/O ADVANCED MEDICAL OPTICS, INC., 1700 E. ST. ANDREW PLACE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) SANTA ANA, CA 92705 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 17,192 (1) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	05/27/2005	03/03/2013	Common Stock	7,997 (2)	$ 12.51	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	03/03/2013	Common Stock	88,340 (2)	$ 12.51	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	05/23/2006	Common Stock	21,012 (2)	$ 13.53	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	05/23/2006	Common Stock	7,957 (2)	$ 13.53	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/12/2012	Common Stock	4,242 (2)	$ 23.58	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/12/2012	Common Stock	140,264 (2)	$ 23.58	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/12/2011	Common Stock	140,426 (2)	$ 24.51	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/12/2011	Common Stock	4,080 (2)	$ 24.51	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/13/2011	Common Stock	513,802 (2)	$ 24.76	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/11/2014	Common Stock	109,139 (2)	$ 30.73	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/11/2014	Common Stock	3,254 (2)	$ 30.73	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/17/2010	Common Stock	6,290 (2)	$ 40.2	D	Â
Employee Stock Option (Right to Buy)	05/27/2005	02/17/2010	Common Stock	57,934 (2)	$ 40.2	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
DAVILA ELIZABETH H C/O ADVANCED MEDICAL OPTICS, INC. 1700 E. ST. ANDREW PLACE SANTA ANA, CA 92705	  X	Â	Â	Â

Signatures

Elizabeth H. Davila, by Aimee S. Weisner, Attorney-in-Fact		05/31/2005
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Received in exchange for an aggregate of 31,145 shares of VISX, Incorporated Common Stock held by the reporting person immediately prior to the merger of such company with and into a wholly owned subisidiary of the issuer (the "Merger"), which became effective on May 27, 2005.
(2)	Received in the Merger in exchange for an employee stock option to acquire shares of VISX, Incorporated common stock. All such converted stock options were vested in full on May 27, 2005.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.